Skip to content
English
Svenska
ASCELIA
AN ONCOLOGY-DEDICATED DRUG DEVELOPMENT COMPANY
About us
Management
Board of Directors
Diseases
Liver metastases
Gastric Cancer
Pipeline
Mangoral
Clinical Development Mangoral
Oncoral
Clinical Development Oncoral
Oncoral Phase 2 Plans
IR & Media
Press releases & News
Reports & Presentations
Share
Shareholders
Equity research
Subscribe to press releases
Ascelia Pharma in Media
IPO (completed 2019)
IR Contact
Financial calendar
CMD 2020
Events
Corporate governance
General Meeting
Articles of Association
Nomination Committee
Board of Directors
Audit Committee
Remuneration Committee
Commercialization Committee
Remuneration
Auditors
Internal control
Career
Open positions
Open applications
Our values
Meet us
Contact
Financial reports
Annual report
Annual Report 2017-2018 FINAL (English version)
Interim report
Video